DISCLOSURE OF HOME MEMBER STATE BY COLOPLAST FINANCE B.V.
NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES. NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON IN ANY JURISDICTION WHERE RELEASE, PUBLICATION OR DISTRIBUTION TO SUCH PERSON IS RESTRICTED BY ANY LAW OR REGULATION APPLICABLE IN SUCH JURISDICTION.
THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR ISSUE OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES.
Coloplast A/S has raised EUR 2.2 billion in debt financing through the issuance by Coloplast Finance B.V. of senior unsecured notes. The notes are unconditionally and irrevocably guaranteed by Coloplast A/S and listed at Nasdaq Copenhagen.
Pursuant to the transparency directive (EU Directive 2004/109/EC, as amended), issuers of securities admitted to trading on a regulated market in the European Union must disclose its home member state. Coloplast Finance B.V. hereby discloses that the home member state of the notes shall be Denmark.
Consequently, Coloplast Finance B.V. is subject to the disclosure requirements in the Danish Act on Capital Markets and executive orders issued pursuant hereto.
For further information, please contact
Investors and analysts
Aleksandra Dimovska
Director, Investor Relations
Tel. +45 4911 1800 /+45 4911 2458
Email: dkadim@coloplast.com
Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com
Address
Coloplast Finance B.V.
Holtedam 1 Dageløkke
DK-3050 Humlebaek
Denmark
Company reg. (CCI) no. 85856819
Website
www.coloplast.com
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice & Respiratory Care. We operate globally and employ about 14,000 employees.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-06.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.
Attachment
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…